Uniphar reports double-digit earnings growth
24th Feb 2026 12:47
(Sharecast News) - Uniphar reported double-digit earnings growth for 2025 on Tuesday, with organic gross profit increasing at its fastest rate since IPO and adjusted earnings per share up 21%, as the group reiterated confidence in its medium-term EBITDA target.
Read moreUniphar ends year with stronger-than-expected earnings growth
27th Jan 2026 13:52
(Sharecast News) - Uniphar reported stronger-than-expected earnings growth in 2025 on Tuesday, supported by robust organic performance across its divisions, lower finance costs and the benefit of its share buyback programme.
Read moreDirector dealings: DFS non-exec invests, Uniphar CEO sells down stake
13th Nov 2025 14:12
(Sharecast News) - Director dealings at DFS Furniture and Uniphar were disclosed on Thursday, with share purchases reported at the UK sofa retailer and a sizable disposal recorded at the Irish healthcare services group.
Read moreUniphar reports strong first half
2nd Sep 2025 10:45
(Sharecast News) - Uniphar reported a strong first half on Tuesday, with double-digit earnings growth and solid organic expansion across all three divisions, leaving the group on track to meet full-year expectations.
Read moreUniphar beats forecasts for first-half earnings
29th Jul 2025 15:15
(Sharecast News) - Uniphar reported a strong performance for the first half of 2025 on Tuesday, achieving double-digit adjusted earnings per share growth, surpassing its own expectations.
Read moreUniphar reports strong set of 2024 numbers
25th Feb 2025 12:14
(Sharecast News) - Uniphar reported a strong 2024 on Tuesday, recording an 8.5% increase in revenue to €2.77bn and a 9.6% rise in gross profit to €427.6m.
Read moreUniphar flags strong full-year trading performance
28th Jan 2025 12:58
(Sharecast News) - Healthcare services business Uniphar reported a strong trading performance for the year ended 31 December in an update on Tuesday, in line with expectations.
Read moreUniphar reports first-half growth across its divisions
3rd Sep 2024 10:14
(Sharecast News) - International diversified healthcare service provider Uniphar reported a solid set of first-half financial results on Tuesday, with notable growth across all of its divisions.
Read moreUniphar flags positive first-half performance
30th Jul 2024 12:22
(Sharecast News) - Healthcare services business Uniphar announced a positive unaudited trading update for the six months ended 30 June on Tuesday.
Read moreUniphar upbeat after successful 2023
9th May 2024 13:11
(Sharecast News) - Uniphar said in an update on Thursday that 2023 was a successful year, as it doubled its 2018 pro-forma EBITDA, ahead of the timeframe it laid out at its initial public offering.
Read moreUniphar posts robust set of full-year results
27th Feb 2024 09:35
(Sharecast News) - Healthcare services company Uniphar reported a robust set of preliminary results on Tuesday, with EBITDA rising 17.7%, as it achieved a return on capital employed of 15.2% and maintained year-end leverage at 1.6x.
Read moreUniphar ends year in line with expectations
30th Jan 2024 12:33
(Sharecast News) - Pharmaceutical and medical technology service company Uniphar said in an update on Tuesday that its performance in 2023 met its own expectations in terms of gross profit and EBITDA, while also achieving normalised free cash flow conversion in line with medium-term guidance.
Read moreUniphar gross profit jumps in first half
14th Sep 2023 12:27
(Sharecast News) - Healthcare services company Uniphar reported gross profit growth of 28.6% in its first half on Thursday, of which 5.5% was organic, representing progress across all divisions.
Read moreUniphar maintains expectations amid strong trading
11th May 2023 12:19
(Sharecast News) - Uniphar reported strong performance over the last year in an update on Thursday, reporting further progress towards its financial and strategic objectives.
Read moreUniphar upbeat on strong full-year performance
28th Feb 2023 16:14
(Sharecast News) - Healthcare service provider Uniphar reported a strong full-year performance on Tuesday, with EBITDA growth of 13.4%, return on capital employed of 17.3%, and year-end leverage of 1.0x.
Read more